CurrentEndo
Get Weekly

Topic · page 94 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,721–3,760 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients ( TROPHIES ): Final patient‐reported outcomes at 24 months

    Cohort study

  2. Obesity (Silver Spring)

    Cumulative BMI and incident prediabetes over 30 years of follow‐up: The CARDIA study

    Cohort study

  3. Diabetologia

    Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

    Cohort study

  4. Diabet Med

    Dapagliflozin improves erectile dysfunction in patients with type 2 diabetes mellitus: An open‐label, non‐randomized pilot study

    Randomized controlled trial

  5. Diabet Med

    Intergenerational differences in healthy eating beliefs among British Pakistanis with type 2 diabetes

    Research article

  6. J Clin Endocrinol Metab

    Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes

    Cross-sectional study

  7. Diabetes Care

    Family Typology for Adults With Type 2 Diabetes: Longitudinal Stability and Validity for Diabetes Management and Well-being

    Diagnostic or prognostic study

  8. Cardiovasc Diabetol

    Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease

    Cross-sectional study

  9. Cardiovasc Diabetol

    Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis

    Cross-sectional study

  10. Diabetes Care

    Empagliflozin Normalizes Fasting Hyperglycemia and Improves Postprandial Glucose Tolerance in Totally Pancreatectomized Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

    Randomized controlled trial

  11. J Clin Endocrinol Metab

    Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies

    Meta-analysis

  12. BMJ Open Diabetes Res Care

    Uncovering heterogeneous cardiometabolic risk profiles in US adults: the role of social and behavioral determinants of health

    Cross-sectional study

  13. BMJ Open Diabetes Res Care

    Detailed descriptions of physical activity patterns among individuals with diabetes and prediabetes: the Lolland-Falster Health Study

    Cross-sectional study

  14. Diabetes Res Clin Pract

    The effectiveness of motivational interviewing on adherence to wearing orthopedic shoes in people with diabetes at low-to-high risk of foot ulceration: A multicenter cluster-randomized controlled trial

    Randomized controlled trial

  15. Diabetes Res Clin Pract

    Effect of diabetes mellitus on young female patients with acute coronary syndrome

    Cohort study

  16. Diabetes Res Clin Pract

    Dietary patterns, socioeconomic disparities, and risk of type 2 diabetes in the Sister Study

    Cohort study

  17. Ann Intern Med

    Chronotype, Unhealthy Lifestyle, and Diabetes Risk in Middle-Aged U.S. Women : A Prospective Cohort Study

    Cohort study

  18. Diabet Med

    ‘I accept his manhood is on life‐support’: A qualitative understanding of the impact of diabetes on sexual relationships among men and women living with type 2 diabetes and their partners in South Africa

    Research article

  19. Diabetes Obes Metab

    The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes ( TROPHIES ): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes

    Cohort study

  20. Lancet Diabetes Endocrinol

    Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

    Cohort study

  21. Diabetes Obes Metab

    Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes

    Research article

  22. Diabetes Obes Metab

    L ow‐density lipoprotein cholesterol and non‐high‐density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German–Austrian diabetes registry

    Cross-sectional study

  23. Diabetes Obes Metab

    Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate‐exposed human islets

    Mechanistic study

  24. Osteoporos Int

    Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis

  25. Diabetes Care

    Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes

    Cohort study

  26. Cardiovasc Diabetol

    Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium

    Cohort study

  27. Cardiovasc Diabetol

    Triglyceride-glucose index and heart failure: a systematic review and meta-analysis

    Meta-analysis

  28. Diabetes Care

    Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials

    Meta-analysis

  29. Diabetes Obes Metab

    The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial

    Secondary analysis

  30. Diabet Med

    Genetic scores associated with favourable and unfavourable adiposity have consistent effect on metabolic profile and disease risk across diverse ethnic groups

    Research article

  31. Diabetes Obes Metab

    Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis

    Meta-analysis

  32. Diabetes Obes Metab

    No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE)

    Randomized controlled trial

  33. JAMA Netw Open

    Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial

    Randomized controlled trial

  34. JAMA Netw Open

    Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes

    Research article

  35. JAMA Netw Open

    Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes

    Cohort study

  36. Obesity (Silver Spring)

    The tissue‐specific metabolic effects of the PPARα agonist ciprofibrate in insulin‐resistant male individuals: a double‐blind, randomized, placebo‐controlled crossover study

    Randomized controlled trial

  37. JAMA Netw Open

    Visit and Between-Visit Interaction Frequency Before and After COVID-19 Telehealth Implementation

    Cohort study

  38. Cardiovasc Diabetol

    Ethnic differences in the association between age at diagnosis of diabetes and the risk of cardiovascular complications: a population-based cohort study

    Cohort study

  39. Diabetes Res Clin Pract

    Optimal cutoffs of sleep timing and sleep duration for cardiovascular risk factors

    Cross-sectional study

  40. Diabet Med

    A real‐life comparison of hypoglycaemia symptomatology between insulin‐treated type 2 diabetes participants with and without impaired awareness of hypoglycaemia

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 3,721–3,760 of 4,758, newest first